ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Price Up 6.1% – Time to Buy?

ChronoScale Corporation Common Stock (NASDAQ:CHRN) shot up 6.1% during mid-day trading on Thursday. The stock traded as high as $21.83 and last traded at $21.77. 47,575 shares changed hands during trading, a decline of 80% from the average daily volume of 233,863 shares. The stock had previously closed at $20.51.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on CHRN shares. Weiss Ratings raised ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research note on Monday, August 24th. Northland Securities began coverage on shares of ChronoScale Corporation Common Stock in a report on Friday, September 18th. They issued an “outperform” rating and a $32.00 target price for the company. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $19.00.

ChronoScale Corporation Common Stock Price Performance

The company has a market cap of $2.89 billion, a price-to-earnings ratio of -3.69 and a beta of 0.98. The company has a fifty day simple moving average of $21.09 and a two-hundred day simple moving average of $17.43. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.06.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its quarterly earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share (EPS) for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The firm had revenue of $18.40 million for the quarter. On average, equities research analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current fiscal year.

Hedge Funds Weigh In On ChronoScale Corporation Common Stock

A hedge fund recently raised its stake in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc raised its holdings in ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,338 shares of the company’s stock after purchasing an additional 1,195 shares during the period. Roble Belko & Company Inc owned 0.07% of ChronoScale Corporation Common Stock worth $25,000 at the end of the most recent reporting period. 6.42% of the stock is owned by hedge funds and other institutional investors.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.